G9152 HCPCS Level II code: Mapcp demonstration - community health teams
G9152 is the HCPCS code for “Mapcp demonstration - community health teams” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9152Mapcp demonstration - community health teams
Short description: Mapcp demo community
HCPCS · United States
Medicare details
The indicators CMS publishes with G9152 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jul 1, 2011
Where G9152 sits
- 1G codesProcedures and professional services
- 2Active code G9152Mapcp demonstration - community health teams
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9152 mean?
G9152 is the HCPCS code for “Mapcp demonstration - community health teams” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9152?
CMS lists G9152’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9152
All G codesG9143Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)G9147Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea…G9148National committee for quality assurance - level 1 medical homeG9149National committee for quality assurance - level 2 medical homeG9150National committee for quality assurance - level 3 medical homeG9151Mapcp demonstration - state provided servicesG9153Mapcp demonstration - physician incentive poolG9156Evaluation for wheelchair requiring face to face visit with physicianG9157Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposesG9158Motor speech functional limitation, discharge status, at discharge from therapy or to end reportingG9159Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervalsG9160Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting